Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
Status:
Terminated
Trial end date:
2018-02-14
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine if adults and children with neurofibromatosis type 1 who
have plexiform tumors given Sutent® respond to this drug therapy.